ArticleHaematologica2025

Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemoimmunotherapy on the SWOG S0016 trial.

Alexey V Danilov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.